<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" dms-id="H4DD2864DE29A45649EC5D3A3837CB23D" public-private="public" bill-type="olc"> 
<metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>109 HR 563 IH: Prescription Drug Affordability Act of 2005</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2005-02-02</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form> 
<distribution-code display="yes">I</distribution-code> 
<congress>109th CONGRESS</congress>
<session>1st Session</session>
<legis-num>H. R. 563</legis-num> 
<current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber> 
<action> 
<action-date date="20050202">February 2, 2005</action-date> 
<action-desc><sponsor name-id="L000562">Mr. Lynch</sponsor> introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name>, and in addition to the Committee on <committee-name committee-id="HWM00">Ways and Means</committee-name>, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned</action-desc>
</action> 
<legis-type>A BILL</legis-type> 
<official-title>To amend part D of title XVIII of the Social Security Act to require the Secretary of Health and Human Services to negotiate and disclose lowest possible prices for prescription drug prices for Medicare beneficiaries, and, with respect to the Federal Food, Drug, and Cosmetic Act, to provide waivers that permit such beneficiaries to import prescription drugs from Canada.</official-title> 
</form> 
<legis-body id="H109BBCA97B8D4CB9B0EB66AF7973E4C5" style="OLC"> 
<section id="HF6778F09B2BB49FB8C4B4992BEB01B47" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Prescription Drug Affordability Act of 2005</short-title></quote>. </text></section> 
<section section-type="subsequent-section" id="H12890F66762841269C5BF4DEEDE2D0A6" display-inline="no-display-inline"><enum>2.</enum><header>Negotiation and disclosure of lowest possible prices for prescription drugs under Medicare</header><text display-inline="no-display-inline">Section 1860D–11 of the <act-name parsable-cite="SSA">Social Security Act</act-name> (<external-xref legal-doc="usc" parsable-cite="usc/42/1395w-111">42 U.S.C. 1395w–111</external-xref>) is amended by striking subsection (i) (relating to noninterference) and by inserting the following:</text> 
<quoted-block act-name="Social Security Act" id="H088F8555584A4E1885887D7EC5DB3C4C"> 
<subsection id="HCB9F1AEB2561462A801FE5725E68072B"><enum>(i)</enum><header>Negotiation and disclosure of best prices</header> 
<paragraph id="H491EE72D63F6431D89B15900806E3C39"><enum>(1)</enum><header>Negotiation</header><text>In order to ensure that beneficiaries enrolled under prescription drug plans and MA–PD plans pay the lowest possible price, the Secretary shall have and exercise authority similar to that of the Secretary of Veterans Affairs, the Secretary of Defense, and the heads of other Federal agencies and departments that purchase prescription drugs in bulk to negotiate contracts with manufacturers of covered part D drugs, consistent with the requirements and in furtherance of the goals of providing quality care and containing costs under this part. In exercising such authority, the Secretary shall negotiate the best possible prices for such drugs.</text></paragraph> 
<paragraph id="H0D247BB9BD6A4D4C939C6F70077BC56D"><enum>(2)</enum><header>Disclosure</header><text>The Secretary shall widely disseminate information on the prices for covered part D drugs negotiated under paragraph (1).</text></paragraph></subsection><after-quoted-block>.</after-quoted-block></quoted-block></section> 
<section id="H22C05A32B4D141379270567C03680581"><enum>3.</enum><header>Medicare beneficiaries; waiver requirement for personal importation of prescription drugs from Canada</header> 
<subsection id="H91A96D401F234C27BC54E8D208DDC84"><enum>(a)</enum><header>In general</header><text display-inline="yes-display-inline"> With respect to the importation by Medicare beneficiaries of prescription drugs from Canada, the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, shall in accordance with this section establish by regulation a waiver of prohibitions under the Federal Food, Drug, and Cosmetic Act that apply to the importation of drugs. Such a waiver shall permit such a beneficiary to import into the United States any prescription drug that—</text> 
<paragraph id="H3466A1D413C5419AB15D30AFF5FA9435"><enum>(1)</enum><text>is imported from Canada for personal use by the beneficiary (not for resale);</text></paragraph> 
<paragraph id="HFB75FB84784A4CF68F5793C1F29D418B"><enum>(2)</enum><text>is approved by the Secretary under section 505 of such Act, is manufactured in an establishment registered with the Secretary under section 510 of such Act, and is not a controlled substance in schedule I, II, or III under section 202(c) of the Controlled Substances Act;</text></paragraph> 
<paragraph id="HD16236F359FE409BB8D4FDE700EB51FA"><enum>(3)</enum><text>is imported from a Canadian pharmacy that has submitted to the Secretary a registration that identifies the pharmacy and provides documentation that the pharmacy is licensed in Canada;</text></paragraph> 
<paragraph id="H62CB947A241E46419C9F8D661902BC83"><enum>(4)</enum><text>is imported in a quantity that does not (for that instance of importation) exceed a 90-day supply;</text></paragraph> 
<paragraph id="H27DDD0B94B3B4391A0FF70A8183503F7"><enum>(5)</enum><text>at the time of importation, is accompanied by a copy of a valid prescription for the drug for the beneficiary, issued in the United States by a practitioner in accordance with section 503(b) of the Federal Food, Drug, and Cosmetic Act, or is accompanied by documentation that verifies the issuance of such a prescription for the beneficiary;</text></paragraph> 
<paragraph id="HC5DB93056C2F4F20AD2C1D42EA8C9992"><enum>(6)</enum><text>is in the form of a final finished dosage; and</text></paragraph> 
<paragraph id="HCF5EAD316E904E27BDAF7E3EE1DB05E"><enum>(7)</enum><text>is imported under such other conditions as the Secretary determines to be necessary to ensure public safety.</text></paragraph></subsection> 
<subsection id="HC6AF422A3E4C4DCB957B6FAD0000A347"><enum>(b)</enum><header>Definitions</header><text display-inline="yes-display-inline">For purposes of subsection (a):</text> 
<paragraph id="H86B37D7FDD7B4A88AC97E928A7BDE292"><enum>(1)</enum><text>The term <quote>Medicare beneficiary</quote> means an individual who is entitled to benefits under, or enrolled in, part A of title XVIII of the Social Security Act, enrolled under part B of such title, or both.</text></paragraph> 
<paragraph id="H61C9B83D3BE841FD82FDB724B39058E"><enum>(2)</enum><text>The term <quote>Secretary</quote> means the Secretary of Health and Human Services. </text></paragraph></subsection> </section> 
</legis-body> 
</bill> 

